WASHINGTON – Today, during a Senate Energy and Natural Resources Committee hearing, Senator Ruben Gallego (D-AZ) pressed Bureau of Land Management (BLM) officials on the agency’s staffing shortages, Arizona renewable energy projects, and Tribal partnerships. Watch Senator Gallego’s questioning HERE. In his opening remarks, Senator Gallego underscored the dangers of BLM’s staffing crisis, which undermines Arizona’s land management goals. “We’ll get to some of the Arizona questions specifically, but first I want to point out an underlying challenge that impacts every potential use of public lands, which is staffing,” said Senator Gallego. “Regardless of what use you’d like to see BLM lands go to, you need BLM staff to get

WASHINGTON – Today, Senator Ruben Gallego (D-AZ) read excerpts of Epstein survivor Virginia Giuffre’s memoir, Nobody’s Girl, on the Senate floor. Watch Senator Gallego’s speech HERE and read it below: “I want us to remember what’s really at stake here. This isn’t about Democrats versus Republicans, it’s about real girls who were hurt, abused, and trafficked by Jeffrey Epstein and the powerful people who surrounded him. “One of those girls was Virginia Roberts Giuffre. She was forced to stay silent for years, but today, I want to let her speak in her own words.   “Virginia was just sixteen when she started working at Mar-a-Lago, where she met Epstein’s recruiter,

WASHINGTON – Today, Senator Ruben Gallego (D-AZ) called on drug manufacturers Eli Lilly and Novo Nordisk to clarify the companies’ agreement with the Trump administration on anti-obesity medications (AOMs), direct to consumer pricing through the TrumpRx drug purchasing platform, and the implementation of “Most Favored Nation” (MFN) pricing in Medicaid. READ MORE: Gallego demands answers on Eli Lilly’s deal with Trump (The Hill) “To date, only sparse details have been provided despite the significance of this arrangement for millions of patients,” Senator Gallego wrote in letters to Eli Lilly Chair and CEO David Ricks and Novo Nordisk CEO Mike Doustdar. “While I support the expansion of Medicare coverage for anti-obesity